kynurenine has been researched along with harmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Crowley, JS; Heyes, MP; Markey, SP; Masana, M; Saito, K | 1 |
| Chrisman, IM; Dameron, LS; Hixon, BP; Kolawole, AO; Smirnov, VV | 1 |
2 other study(ies) available for kynurenine and harmine
| Article | Year |
|---|---|
4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Topics: 3-Hydroxyanthranilic Acid; Animals; Brain; Carbolines; Cell Line; Harmine; Humans; Interferon-gamma; Kynurenine; Leukocytes, Mononuclear; Macrophages; Quinolinic Acid; Rats; Tryptophan; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen.
Topics: Binding Sites; Carbolines; Catalysis; Escherichia coli; Harmine; Humans; Immunosuppressive Agents; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Oxygen; Protein Binding; Substrate Specificity; Tryptophan | 2015 |